Issue Date | Title | Author(s) | Source | scopus | WOS | Fulltext/Archive link |
2012 | 10′(Z),13′(E)-Heptadecadienylhydroquinone Inhibits Swarming and Virulence Factors and Increases Polymyxin B Susceptibility in Proteus mirabilis | Liu M.-C.; Lin S.-B.; Chien H.-F.; WON-BO WANG ; Yuan Y.-H.; PO-REN HSUEH ; SHWU-JEN LIAW | PLoS ONE | 15 | 12 | |
1995 | Acute leukemic transformation of myelodysplastic syndrome-Immunophenotypic, genotypic, and cytogenetic studies | HWEI-FANG TIEN ; Wang C.-H.; Chuang S.-M.; Lee F.-Y.; Liu M.-C.; YAO-CHANG CHEN ; MING-CHING SHEN ; Lin K.-H.; Lin D.-T. | Leukemia Research | 16 | 15 | |
2002 | Additional chromosomal abnormalities and variability of BCR breakpoints in Philadelphia chromosome/BCR-ABL-positive acute lymphoblastic leukemia in Taiwan | BOR-SHENG KO ; JIH-LUH TANG ; Lee F.-Y.; Liu M.-C.; Tsai W.; YAO-CHANG CHEN ; Wang C.-H.; Sheng M.-C.; Lin D.-T.; Lin K.-H.; HWEI-FANG TIEN | American Journal of Hematology | 27 | 25 | |
2016 | Afatinib plus vinorelbine versus trastuzumab plus vinorelbine in patients with HER2-overexpressing metastatic breast cancer who had progressed on one previous trastuzumab treatment (LUX-Breast 1): An open-label, randomised, phase 3 trial | Harbeck N.; CHIUN-SHENG HUANG ; Hurvitz S.; Yeh D.-C.; Shao Z.; Im S.-A.; Jung K.H.; Shen K.; Ro J.; Jassem J.; Zhang Q.; Im Y.-H.; Wojtukiewicz M.; Sun Q.; Chen S.-C.; Goeldner R.-G.; Uttenreuther-Fischer M.; Xu B.; Piccart-Gebhart M.; Krasnozhon D.; Tong Z.; Arora R.S.; Jacob L.A.; Staroslawska E.; Wang X.; Satya Suresh Attili V.; Mehta A.O.; Lee S.H.; Tseng M.-L.; Perera N.A.M.; Huizing M.; Melichar B.; Grigiene R.; Bharwani L.; Cortes J.; Garcia M.; Chirgwin J.; Baranau Y.; Ermakov N.; Li W.; Lin T.; Qin S.; Shen P.; Yang J.; Dohollou N.; Kerbrat P.; Uleer C.; Kristeleit H.; Nagarkar R.V.; Crown J.; Kelly C.; Kaufman B.; Ionta M.T.; Park K.H.; Farhat F.; Chin L.S.; Sufliarsky J.; Saenz J.A.G.; Begbie S.; Dittrich C.; Karchmit Y.; Awada A.; Bines J.; Rigo R.; Califaretti N.; Sridhar S.; Villa D.; Jiang Z.; Wang X.; Wu G.; Shu W.; Zheng H.; Delva R.; Pivot X.; Beckmann M.; Bischoff J.; Gerber B.; Maass N.; Richters L.; Schumacher C.; Jain M.M.; Indelli M.; Purkalne G.; Juozaityte E.; Erdkamp F.L.G.; Sanchez F.S.; Susko-Kazamowicz M.; Sousa S.; Mukhametshina G.; Shomova M.; Yap Y.S.; Beniak J.; Grasic C.; Demetriou G.; Maart K.; Pienaar R.; Rapoport B.; Chacon J.I.; Cao M.G.; Chen S.-T.; Chang H.-T.; Kaplan E.; Lawler W.; Carraro S.; Lerzo G.; Chan A.; Snyder R.; Noryk D.; Graas M.-P.; Aleixo S.; Caleffi M.; Franke F.; Hegg R.; Santi P.X.; Vinholes J.; Zereu M.; Ghedira S.; Poirier E.; Yelle L.; Yanez E.; Liu J.; Luo R.; Pecha V.; Petruzelka L.; Azim H.A.; Shamaa S.S.; Brain E.; Chauffert B.; Espie M.; Lortholary A.; Petit T.; Augustin D.; Barinoff J.; Fett W.; Hannig C.V.; Kurbacher C.M.; Otremba B.; Paepke S.; Adamson D.; Kristeleit H.; O'brien M.; Bhattacharyya G.S.; Krishnan S.; Mohan R.; Nag S.; Fried G.; Isacson R.; Nakayama T.; Kudaba I.; Luna G.A.; Dercksen M.W.; Honkoop A.; Tjan-Heijnen V.C.G.; van den Bosch J.; Palominos O.M.; Blasinska-Morawiec M.; Szczylik C.; Wysocki P.; Damasceno M.; Pais A.; Biakhov M.; Chovanec J.; Harris J.; Caranana V.; Lopez R.; Tusquets I.; Chang T.-W.; Liu M.-C.; Altundag K.; Gokmen E.; Avery T.; Chan D.; Kendall S.; Hetzel D.; Kass F.; Singh J.; The LUX-Breast 1 study group | The Lancet Oncology | 103 | 91 | |
2009 | AML1/RUNX1 mutations in 470 adult patients with de novo acute myeloid leukemia: Prognostic implication and interaction with other gene alterations | JIH-LUH TANG ; HSIN-AN HOU ; Chen, Chien-Yuan ; Liu C.-Y.; WEN-CHIEN CHOU ; Tseng M.-H.; Huang C.-F.; Lee F.-Y.; Liu M.-C.; MING YAO ; SHANG-YI HUANG ; BOR-SHENG KO ; SZU-CHUN HSU ; SHANG-JU WU ; WOEI TSAY ; YAO-CHANG CHEN ; LIANG-IN LIN ; HWEI-FANG TIEN | Blood | 281 | 255 | |
2011 | Aristolochic acid I suppressed iNOS gene expression and NF-κB activation in stimulated macrophage cells | Liu M.-C.; Lin T.-H.; Wu T.-S.; Yu F.-Y.; Lu C.-C.; Liu, Biing-Hui | Toxicology Letters | 12 | 9 | |
2008 | Characterization of acute myeloid leukemia with PTPN11 mutation: The mutation is closely associated with NPM1 mutation but inversely related to FLT3/ITD | HSIN-AN HOU ; WEN-CHIEN CHOU ; LIANG-IN LIN ; Chen, Chien-Yuan ; JIH-LUH TANG ; Tseng M.-H.; Huang C.-F.; Chiou R.-J.; Lee F.-Y.; Liu M.-C.; HWEI-FANG TIEN | Leukemia | 58 | 54 | |
1992 | Characterization of Philadelphia-chromosome-positive acute leukemia by clinical, immunocytochemical, and gene analysis | HWEI-FANG TIEN ; Wang C.-H.; Chuang S.-M.; Lee F.-Y.; Liu M.-C.; YAO-CHANG CHEN ; MING-CHING SHEN ; Lin D.-T.; KAI-HSIN LIN ; Lin K.-S.; Liu C.-H. | Leukemia | 31 | 27 | |
2010 | Characterization of UDP-glucose dehydrogenase and UDP-glucose pyrophosphorylase mutants of proteus mirabilis: Defectiveness in polymyxin B resistance, swarming, and virulence | Jiang S.-S.; Lin T.-Y.; WON-BO WANG ; Liu M.-C.; PO-REN HSUEH ; SHWU-JEN LIAW | Antimicrobial Agents and Chemotherapy | 47 | 48 | |
2004 | Chromosomal abnormalities of 200 Chinese patients with non-Hodgkins's lymphoma in Taiwan: With special reference to T-cell lymphoma | Chen, Chien-Yuan ; MING YAO ; JIH-LUH TANG ; WOEI TSAY ; Wang C.-C.; WEN-CHIEN CHOU ; Su I.-J.; Lee F.-Y.; Liu M.-C.; HWEI-FANG TIEN | Annals of Oncology | 41 | 31 | |
2015 | Clinical and prognostic implications of roundabout 4 (Robo4) in adult patients with acute myeloid leukemia | YIN-KAI CHEN ; HSIN-AN HOU ; JIH-LUH TANG ; Jhuang J.-Y.; Lai Y.-J.; Lee M.-C.; Kuo Y.-Y.; WEN-CHIEN CHOU ; Liu C.-Y.; CHUNG-WU LIN ; Chuang S.-S.; Chen, Chien-Yuan ; Tseng M.-H.; Huang C.-F.; Chiang Y.-C.; Lee F.-Y.; Liu M.-C.; Liu C.-W.; MING YAO ; SHANG-YI HUANG ; BOR-SHENG KO ; SZU-CHUN HSU ; SHANG-JU WU ; WOEI TSAY ; YAO-CHANG CHEN ; HWEI-FANG TIEN | PLoS ONE | 7 | 4 | |
2012 | The clinical implication of SRSF2 mutation in patients with myelodysplastic syndrome and its stability during disease evolution | SHANG-JU WU ; Kuo Y.-Y.; HSIN-AN HOU ; Li Y.; Tseng M.-H.; Huang C.-F.; Lee F.-Y.; Liu M.-C.; Liu C.-W.; Lin C.-T.; Chen, Chien-Yuan ; WEN-CHIEN CHOU ; MING YAO ; SHANG-YI HUANG ; BOR-SHENG KO ; JIH-LUH TANG ; WOEI TSAY ; HWEI-FANG TIEN | Blood | 123 | 100 | |
2021 | Clinical implications of sequential MRD monitoring by NGS at 2 time points after chemotherapy in patients with AML | CHENG-HONG TSAI ; JIH-LUH TANG ; FENG-MING TIEN ; YUAN-YEH KUO ; Wu D.-C.; CHIEN-CHIN LIN ; Tseng M.-H.; Peng Y.-L.; Hou M.-F.; Chuang Y.-K.; Liu M.-C.; CHIA-WEN LIU ; MING YAO ; LIANG-IN LIN ; WEN-CHIEN CHOU ; CHIEN-YU CHEN ; HSIN-AN HOU ; HWEI-FANG TIEN | Blood Advances | 27 | 27 | |
2014 | Clinical implications of the SETBP1 mutation in patients with primary myelodysplastic syndrome and its stability during disease progression | HSIN-AN HOU ; Kuo Y.-Y.; JIH-LUH TANG ; WEN-CHIEN CHOU ; MING YAO ; Lai Y.-J.; CHIEN-CHIN LIN ; Chen, Chien-Yuan ; Liu C.-Y.; Tseng M.-H.; Huang C.-F.; Chiang Y.-C.; Lee F.-Y.; Liu M.-C.; Liu C.-W.; SHANG-YI HUANG ; BOR-SHENG KO ; SHANG-JU WU ; WOEI TSAY ; YAO-CHANG CHEN ; HWEI-FANG TIEN | American Journal of Hematology | 58 | 54 | |
2013 | Clinical implications of U2AF1 mutation in patients with myelodysplastic syndrome and its stability during disease progression | SHANG-JU WU ; JIH-LUH TANG ; Lin C.-T.; Kuo Y.-Y.; Li L.-Y.; Tseng M.-H.; Huang C.-F.; Lai Y.-J.; Lee F.-Y.; Liu M.-C.; Liu C.-W.; HSIN-AN HOU ; Chen, Chien-Yuan ; WEN-CHIEN CHOU ; MING YAO ; SHANG-YI HUANG ; BOR-SHENG KO ; WOEI TSAY ; HWEI-FANG TIEN | American Journal of Hematology | 57 | 42 | |
2005 | Clinical significance of cytogenetics and interphase fluorescence in situ hybridization analysis in newly diagnosed multiple myeloma in Taiwan | Huang S.-Y.; MING YAO ; JIH-LUH TANG ; WOEI TSAY ; Lee F.-Y.; Liu M.-C.; Wang C.-H.; YAO-CHANG CHEN ; MING-CHING SHEN ; HWEI-FANG TIEN | Annals of Oncology | 30 | 25 | |
1997 | Clonal chromosomal abnormalities as direct evidence for clonality in nasal T/natural killer cell lymphomas | HWEI-FANG TIEN ; Su I.J.; JIH-LUH TANG ; Liu M.-C.; Lee F.-Y.; YAO-CHANG CHEN ; Chuang S.-M. | British Journal of Haematology | 70 | 60 | |
1998 | Clonal disease of natural killer large granular lymphocytes in Taiwan | WEN-CHIEN CHOU ; Chiang I.-P.; JIH-LUH TANG ; Su I.-J.; SHANG-YI HUANG ; YAO-CHANG CHEN ; Liu M.-C.; Lee F.-Y.U.; Wang C.-H.; MING-CHING SHEN ; Chuang S.-M.; HWEI-FANG TIEN | British Journal of Haematology | 15 | 11 | |
1995 | Correlation of cytogenetic results with immunophenotype, genotype, clinical features, and ras mutation in acute myeloid leukemia A study of 235 Chinese patients in Taiwan | HWEI-FANG TIEN ; Wang C.-H.; Lin M.-T.; Lee F.-Y.; Liu M.-C.; Chuang S.-M.; YAO-CHANG CHEN ; MING-CHING SHEN ; Lin K.-H.; Lin D.-T. | Cancer Genetics and Cytogenetics | 105 | 95 | |
1993 | Cytogenetic characterization of Epstein-Barr virus-associated T-cell malignancies | HWEI-FANG TIEN ; Su I.-J.; Chuang S.-M.; Lee F.-Y.; Liu M.-C.; TSEN-FANG TSAI ; Lin K.-H.; Chen R.-L. | Cancer Genetics and Cytogenetics | 16 | 15 | |